Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
New ways in which GLP-1 can regulate glucose homeostasis
David A. D’Alessio, … , Darleen A. Sandoval, Randy J. Seeley
David A. D’Alessio, … , Darleen A. Sandoval, Randy J. Seeley
Published December 1, 2005
Citation Information: J Clin Invest. 2005;115(12):3406-3408. https://doi.org/10.1172/JCI27207.
View: Text | PDF
Commentary

New ways in which GLP-1 can regulate glucose homeostasis

  • Text
  • PDF
Abstract

Glucagon-like peptide–1 (GLP-1) has a diverse set of peripheral actions which all serve to promote enhanced glucose tolerance, and for this reason it has become the basis for new treatments for type 2 diabetes. In this issue of the JCI, Knauf et al. provide clear evidence that GLP-1 signaling in the CNS is also linked to the control of peripheral glucose homeostasis by inhibiting non–insulin-mediated glucose uptake by muscle and increasing insulin secretion from the pancreas. The authors’ work points to an important need to integrate diverse GLP-1 signaling actions and peripheral GLP-1 function in order to better understand both normal and abnormal glucose homeostasis.

Authors

David A. D’Alessio, Darleen A. Sandoval, Randy J. Seeley

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Levels of glucose in the plasma are determined by the rate at which gluc...
Levels of glucose in the plasma are determined by the rate at which glucose emerges from the gastrointestinal tract as well as the rate of glucose production by the liver. Glucose serves as a stimulus for insulin secretion from the pancreas, which influences the rate of glucose uptake by both liver and muscle. GLP-1 secreted by the intestine inhibits glucose appearance by inhibiting both nutrient intake and gastric emptying rates while stimulating insulin secretion to facilitate muscle and liver glucose uptake. In this issue of the JCI, Knauf et al. (11) provide compelling evidence that GLP-1 signaling in the CNS also serves to increase non–insulin-dependent glucose uptake by muscle and stimulates insulin secretion via neural connections to these tissues.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts